相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of Mutation Profiles in the Duchenne Muscular Dystrophy Gene among Populations: Implications for Potential Molecular Therapies
Luz Berenice Lopez-Hernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
α-dystroglycan is a potential target of matrix metalloproteinase MMP-2
Diego Sbardella et al.
MATRIX BIOLOGY (2015)
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex
Manuela Bozzi et al.
MATRIX BIOLOGY (2015)
Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Tirsa L. E. van Westering et al.
MOLECULES (2015)
Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy
Aleksandar Zocevic et al.
NEUROMUSCULAR DISORDERS (2015)
Dystrophin proteolysis: a potential target for MMP-2 and its prevention by ischemic preconditioning
Bruno Buchholz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Analyses of the presence of mutations in Dystrophin protein to predict their relative influences in the onset of Duchenne Muscular Dystrophy
Simanti Bhattacharya et al.
CELLULAR SIGNALLING (2014)
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
Burcu Ayoglu et al.
EMBO MOLECULAR MEDICINE (2014)
Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy
Giulia Maria Camerino et al.
HUMAN MOLECULAR GENETICS (2014)
Serum mir-206 and other muscle-specific micrornas as non-invasive biomarkers for duchenne muscular dystrophy
Jun Hu et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
Thomas Voit et al.
LANCET NEUROLOGY (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
Biomarkers and surrogate endpoints in Duchenne: Meeting report
Annemieke Aartsma-Rus et al.
NEUROMUSCULAR DISORDERS (2014)
Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy
Jeremy Rouillon et al.
NEUROMUSCULAR DISORDERS (2014)
Fibronectin is a serum biomarker for Duchenne muscular dystrophy
F. Cynthia Martin et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age
Sandra Mercier et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model
Louise R. Rodino-Klapac et al.
HUMAN MOLECULAR GENETICS (2013)
Wasting mechanisms in muscular dystrophy
Jonghyun Shin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice
Sajedah M. Hindi et al.
PLOS ONE (2013)
Myostatin and Insulin-Like Growth Factor I: Potential Therapeutic Biomarkers for Pompe Disease
Yin-Hsiu Chien et al.
PLOS ONE (2013)
Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity
Jian Qin et al.
RESEARCH IN VETERINARY SCIENCE (2013)
Immunodetection analysis of muscular dystrophies in Mexico
Benjamin Gomez-Diaz et al.
MUSCLE & NERVE (2012)
Circulating Follistatin in Patients with Chronic Kidney Disease: Implications for Muscle Strength, Bone Mineral Density, Inflammation, and Survival
Tetsu Miyamoto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
miRNAs as serum biomarkers for Duchenne muscular dystrophy
Davide Cacchiarelli et al.
EMBO MOLECULAR MEDICINE (2011)
Exercise Induces a Marked Increase in Plasma Follistatin: Evidence That Follistatin Is a Contraction-Induced Hepatokine
Jakob Hansen et al.
ENDOCRINOLOGY (2011)
Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers
Daigo Miyazaki et al.
HUMAN MOLECULAR GENETICS (2011)
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)
V. D. Nadarajah et al.
NEUROMUSCULAR DISORDERS (2011)
Antibody-Directed Myostatin Inhibition Improves Diaphragm Pathology in Young but not Adult Dystrophic mdx Mice
Kate T. Murphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular Dystrophy
Katherine D. Mathews et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy
Guilian Sun et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families - Detection of carrier status in symptomatic and asymptomatic female relatives
Henriett Piko et al.
NEUROMUSCULAR DISORDERS (2009)
Expression of Myostatin and Follistatin in Mdx Mice, an Animal Model for Muscular Dystrophy
Shinichi Abe et al.
ZOOLOGICAL SCIENCE (2009)
Myostatin as a therapeutic target for musculoskeletal disease
L. Bradley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Wide ranges of serum myostatin concentrations in Duchenne muscular dystrophy patients
Hiroyuki Awano et al.
CLINICA CHIMICA ACTA (2008)
Activation and localization of matrix metalloproteinase-2 and-9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ)
Kazuhiro Fukushima et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
Correlations of Egen Klassifikation and Barthel Index scores with pulmonary function parameters in Duchenne muscular dystrophy
Marisa Afonso Brunherotti et al.
HEART & LUNG (2007)
Serum levels of matrix metalloproteinases-2 and-9 and their tissue inhibitors in inflammatory neuromuscular disorders
S. Hurnaus et al.
EUROPEAN NEUROLOGY (2006)
MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls
B Janssen et al.
NEUROGENETICS (2005)
Transforming growth factor-β1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle -: A key event in muscle fibrogenesis
Y Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Characterization of 5′-regulatory region of human myostatin gene:: regulation by dexamethasone in vitro
K Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Elevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy
M Ishitobi et al.
NEUROREPORT (2000)
分享论文
